Journal of Clinical Oncology, Vol 16, 567-573, Copyright © 1998 by American Society of Clinical Oncology

ARTICLES

Telomerase activity in pleural effusions: diagnostic significance

CT Yang, MH Lee, RS Lan and JK Chen
Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.

PURPOSE: To determine the diagnostic value of pleural fluid telomerase activity in distinguishing a malignant from a nonmalignant pleurol effusion in a cohort of patients undergoing thoracentesis. PATIENTS AND METHODS: Using a polymerase chain reaction (PCR)-based assay, telomerase activity was examined in the pleural fluid cells obtained from 144 consecutive, unselected patients. According to the final diagnosis achieved, these patients were classified into three groups: group I consisted of 70 malignant pleural effusions diagnosed by either fluid cytology or pleural biopsy, group II consisted of 52 nonmalignant pleural effusions, and another 22 samples were categorized to be suspicious malignant pleural effusions (group III) due to inconclusive results in effusion cytology and percutaneous pleural biopsy, but were strongly suspicious in clinical settings. RESULTS: The presence of telomerase activity was observed in 64 of 70 samples in group I (91.4%), three of 52 samples in group II (5.8%), and 20 of 22 samples in group III. All three nonmalignant, telomerase-positive pleural effusion samples in group II were obtained from patients with tuberculosis. As a diagnostic criterion for malignant pleural effusion in group I and group II patients, positive telomerase activity had a sensitivity of 91.4%, a specificity of 94.2%, and a positive and negative predictive value of 0.96 and 0.89, respectively. CONCLUSION: Our results indicate that the detection of telomerase activity may be a useful adjunct to cytopathologic methods in the diagnosis of malignant pleural effusions.

This article has been cited by other articles:

				K. Passebosc-Faure, G. Li, C. Lambert, M. Cottier, A. Gentil-Perret, P. Fournel, M. Perol, and C. Genin Evaluation of a Panel of Molecular Markers for the Diagnosis of Malignant Serous Effusions Clin. Cancer Res., October 1, 2005; 11(19): 6862 - 6867. [Abstract] [Full Text] [PDF]

				M. Fiegl, M. Haun, A. Massoner, J. Krugmann, E. Muller-Holzner, R. Hack, W. Hilbe, C. Marth, H.-C. Duba, G. Gastl, et al. Combination of Cytology, Fluorescence In Situ Hybridization for Aneuploidy, and Reverse-Transcriptase Polymerase Chain Reaction for Human Mammaglobin/Mammaglobin B Expression Improves Diagnosis of Malignant Effusions J. Clin. Oncol., February 1, 2004; 22(3): 474 - 483. [Abstract] [Full Text] [PDF]

				S K Mohanty and P Dey Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review Postgrad. Med. J., October 1, 2003; 79(936): 569 - 574. [Abstract] [Full Text] [PDF]

				G. Dikmen, E. Dikmen, M. Kara, E. Sahin, P. Dogan, and N. Ozdemir Diagnostic implications of telomerase activity in pleural effusions Eur. Respir. J., September 1, 2003; 22(3): 422 - 426. [Abstract] [Full Text] [PDF]

				E. Dikmen, M. Kara, G. Dikmen, H. Cakmak, and P. Dogan Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 194 - 199. [Abstract] [Full Text] [PDF]

				M. Golshan, M. Faghihi, K. Ghanbarian, and M. Ghanei Common Causes of Pleural Effusion in Referral Hospital in Isfahan, Iran 1997-1998 Asian Cardiovasc Thorac Ann, March 1, 2002; 10(1): 43 - 46. [Abstract] [Full Text] [PDF]

				J. L. Hess and W. E. Highsmith Jr Telomerase Detection in Body Fluids Clin. Chem., January 1, 2002; 48(1): 18 - 24. [Abstract] [Full Text] [PDF]

				M. Arinaga, S. Shimizu, K. Gotoh, N. Haruki, T. Takahashi, T. Takahashi, and T. Mitsudomi Expression of human telomerase subunit genes in primary lung cancer and its clinical significance Ann. Thorac. Surg., August 1, 2000; 70(2): 401 - 405. [Abstract] [Full Text] [PDF]

				P. Tangkijvanich, D. Tresukosol, P. Sampatanukul, S. Sakdikul, N. Voravud, V. Mahachai, and A. Mutirangura Telomerase Assay for Differentiating between Malignancy-related and Nonmalignant Ascites Clin. Cancer Res., September 1, 1999; 5(9): 2470 - 2475. [Abstract] [Full Text] [PDF]

				C. Poremba, K. R. Shroyer, M. Frost, R. Diallo, F. Fogt, K.-L. Schafer, H. Burger, A. L. Shroyer, B. Dockhorn-Dworniczak, and W. Boecker Telomerase Is a Highly Sensitive and Specific Molecular Marker in Fine-Needle Aspirates of Breast Lesions J. Clin. Oncol., July 1, 1999; 17(7): 2020 - 2020. [Abstract] [Full Text] [PDF]